RE:RE:Question for the Pharma Savvy
That is the most negative take you could have of the last few news releases. Of course value is not the stock price but revenue from the cancer division, any possible deals and even approvals from the FDA would add value which they don't have yet.
What these news releases do is preview what future value looks like but more importantly it's ammunition to use in making a deal now or in the near future.
Saying all they are doing is saving mice is silly especially when they are 2/3 of the way through a Phase II trial for bladder cancer. With best in class results too.
I drank Kool-Aid as a kid but not anymore, this is serious business and I don't think "most of us" are thinking the way you are. The stock price has been a victim of their need for cash and we've had head fakes in the past but we'll see if the recent action is sustainable or another PP holds it back again.